Royal Bank of Canada’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,481
Closed -$8K 7491
2019
Q1
$8K Sell
12,481
-250
-2% -$157 ﹤0.01% 6119
2018
Q4
$5K Sell
12,731
-1,656
-12% -$1.14K ﹤0.01% 6202
2018
Q3
$15K Buy
14,387
+1,398
+11% +$1.58K ﹤0.01% 5839
2018
Q2
$15K Sell
12,989
-7
-0.1% -$10 ﹤0.01% 5692
2018
Q1
$21K Buy
12,996
+2,587
+25% +$4.55K ﹤0.01% 5444
2017
Q4
$18K Buy
10,409
+840
+9% +$1.74K ﹤0.01% 5645
2017
Q3
$23K Buy
9,569
+729
+8% +$2.46K ﹤0.01% 5892
2017
Q2
$33K Buy
8,840
+4,781
+118% +$16.3K ﹤0.01% 5327
2017
Q1
$11K Sell
4,059
-147
-3% -$372 ﹤0.01% 5948
2016
Q4
$9K Buy
4,206
+616
+17% +$1.81K ﹤0.01% 6142
2016
Q3
$12K Hold
3,590
﹤0.01% 5745
2016
Q2
$48K Buy
3,590
+1,000
+39% +$16.6K ﹤0.01% 5155
2016
Q1
$42K Sell
2,590
-1,541
-37% -$21.1K ﹤0.01% 5206
2015
Q4
$65K Sell
4,131
-4,761
-54% -$81.6K ﹤0.01% 5183
2015
Q3
$127K Buy
8,892
+3,694
+71% +$62.6K ﹤0.01% 4621
2015
Q2
$116K Buy
5,198
+1,576
+44% +$39.5K ﹤0.01% 4734
2015
Q1
$73K Buy
3,622
+55
+2% +$1.02K ﹤0.01% 4780
2014
Q4
$59K Buy
3,567
+917
+35% +$14.3K ﹤0.01% 4991
2014
Q3
$40K Buy
2,650
+250
+10% +$4.94K ﹤0.01% 5053
2014
Q2
$60K Buy
2,400
+1,167
+95% +$26.6K ﹤0.01% 4758
2014
Q1
$26K Buy
1,233
+1,066
+638% +$37.8K ﹤0.01% 5110
2013
Q4
$6K Hold
167
﹤0.01% 5587
2013
Q3
$3K Sell
167
-6
-3% -$88 ﹤0.01% 5826
2013
Q2
$2K Buy
+173
New +$2.55K ﹤0.01% 5675

Other funds holding CYTR

Royal Bank of Canada's CYTR Position: Q2 2019 in Review

Royal Bank of Canada sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 12,481 shares — an estimated $8K sold.

Royal Bank of Canada first reported a position in CYTR in Q2 2013 and held it in 24 quarters. The position peaked at $127K in Q3 2015. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

  • Royal Bank of Canada reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 12,481 CytRx Corp shares in Q2 2019, an estimated $8K.
  • Royal Bank of Canada first reported a position in CytRx Corp in Q2 2013 and held it in 24 quarters.
  • Royal Bank of Canada's CytRx Corp position peaked at $127K in Q3 2015.
  • 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on Royal Bank of Canada's 13F filing for Q2 2019, filed 14 Aug 2019.